Autonomix Medical, Inc. Common Stock
Here’s whether Autonomix Medical, Inc. Common Stock (AMIX) is worth buying in 2026 — based on weekly-updated price trend, RSI momentum, and return vs. the S&P 500. Our current read: Bearish.
Concerns: trading below the 200-day MA (long-term downtrend); below the 50-day MA (medium-term momentum negative); 50-day MA is falling (-8.26% over 10 days); RSI 4 — oversold; weak 1-year return of -90.3%; 3-month momentum negative (-62.3%); rising volume on a downtrend (distribution, 2.91x avg). Currently 91.0% off its 52-week high. Score: -7/7.
AMIX is trading below its 200-day MA ($11.35) — a key warning sign the longer-term trend is under pressure. An RSI of 4.1 has dropped into oversold territory, which has historically preceded short-term bounces. The 1-year return of -90.3% compares to +16.5% for SPY (trailed the market by 106.8%). The current 91.0% drawdown from the 52-week high reflects elevated risk for momentum-based strategies.